MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: Diosgenin also enhanced ROS-dependent autophagy and cytotoxicity in chronic myeloid leukemia cells via inhibition of mammalian target of rapamycin (mTOR) signaling pathway [94].